Fundraising Fox
Dementia Discovery
Venture capitalLondon · Seed–Series C · 15 people tracked
Also known as Dementia Discovery Fund
Find your way into Dementia Discovery
988 people in our graph can introduce you to the Dementia Discovery team.
Sign up to see every warm intro you have to Dementia Discovery
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dementia Discovery team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
DDF backs bold entrepreneurs across the full spectrum of company and asset stages within dementia therapeutics, and creates new biotech companies itself where none exist. Its mandate is to interrogate novel hypotheses and expand the breadth of targets and mechanisms for dementia therapies, investing in early-stage projects from target identification onward to translate novel biology into disease-modifying drugs. Covering Alzheimer's and other dementias such as PDD, FTD, ALS and HD, the fund pursues a dual mandate of delivering measurable patient impact and generating strong financial returns, drawing on a network of venture partners, entrepreneurs, scientists and strategic pharmaceutical partners.
Source: firm website, verified Aug 3, 2026.
Team · 15 people
from curated & public directories
Founder mafia
The Dementia Discovery mafia →6 people who came through Dementia Discovery went on to found or lead other companies.
What they invest in
from 3 of 3 portfolio companiesBiotech ×3Deep Tech ×3Healthtech ×2AI & Machine Learning ×1Digital Health ×1Medical Devices ×1
HQs:United States×2United Kingdom×1
Investments · 3 tracked
founders shown can be your intro pathViolet is a therapeutics company developing small molecule treatments for central nervous system diseases, using its proprietary C-to-C Engine platform to identify disease-relevant cell-to-cell interactions.
BiotechDeep TechCambridge, US
William E Yelle(Executive Officer, Director)Atsushi Usami(Director)Meredith Fisher(Executive Officer, Director)Jonathan Behr(Director)
Board seatJonathan Behr· per SEC Form D
Co-investorsDementia Discovery FundLifespan Vision VenturesOno Venture Investment, Inc.SV Health InvestorsUTEC
AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
BiotechDeep TechDigital HealthHealthtech
Chris Shaw(Co-Founder & Chief Scientific and Clinical Advisor)inDo Young Lee(Co-Founder)Youn Bok Lee(Co-Founder)inLisa Deschamps(Chief Executive Officer)inGraeme Fielder(Chief Operating Officer)inAlex Bloom(Chief Development Officer)in
Co-investorsAdvent Life SciencesF-Prime CapitalLifeArc VenturesMonograph Capital PartnersNew Enterprise Associates (NEA)SV Health Investors
Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US
Craig Thompson(Chief Executive Officer)inSagar Vaidya(Chief Medical Officer)inCarrie Ann Cook(Chief Business Officer)Mark Carlton(Chief Scientific Officer)inOttavio V. Vitolo(Chief Medical Officer)in
Co-investorsDementia Discovery FundForesite CapitalGV (Google Ventures)SV Life SciencesDolby Family VenturesLightstone Ventures+3 more
Frequently asked questions
- What stage does Dementia Discovery invest at?
- Dementia Discovery invests at the Seed, Series A, Series B, Series C stages.
- What sectors does Dementia Discovery focus on?
- Dementia Discovery focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Longevity, Medical Devices.
- Where is Dementia Discovery located?
- Dementia Discovery is headquartered in London, GB.
- Does Dementia Discovery lead rounds?
- Dementia Discovery typically participates in rounds rather than leading them.
- Who does Dementia Discovery co-invest with?
- Dementia Discovery most often shares deals with Dementia Discovery Fund, F-Prime Capital, GV (Google Ventures), among 13 tracked co-investors.
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Tenmile is an Australia-based venture firm investing in health and life sciences companies from seed stage onward, aiming to connect Australian innovation to global markets.
Portfolia operates thematic venture funds designed by and for women investors, backing companies in women's health, active aging, and longevity, alongside a community of over 2,200 women investors across 48 states and 20 countries.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.